Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
13.32
+0.53 (4.14%)
At close: Dec 8, 2025, 4:00 PM EST
13.31
-0.01 (-0.08%)
After-hours: Dec 8, 2025, 5:59 PM EST
Arvinas Market Cap
Arvinas has a market cap or net worth of $855.47 million as of December 8, 2025. Its market cap has decreased by -42.47% in one year.
Market Cap
855.47M
Enterprise Value
66.25M
1-Year Change
-42.47%
Ranking
Category
Stock Price
$13.32
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $855.47M, an increase of 65.74%. That is a compound annual growth rate of 7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 821.43M | -37.64% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |